Citation: La. Wright et al., EX-VIVO EFFECTS ASSOCIATED WITH THE EXPRESSION OF A BCR-ABL-SPECIFIC RIBOZYME IN A CML CELL-LINE, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 8(1), 1998, pp. 15-23
Authors:
ATKINSON K
NIVISONSMITH I
DODDS A
CONCANNON A
MILLIKEN S
DOWNS K
Citation: K. Atkinson et al., A COMPARISON OF THE PATTERN OF INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BEFORE AND AFTER THE INTRODUCTION OF PROPHYLACTIC GANCICLOVIR THERAPY IN 1989, Bone marrow transplantation, 21(7), 1998, pp. 691-695
Citation: Aj. Davis et al., LONG-TERM FOLLOW-UP OF CEOP IN THE TREATMENT OF HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL), Australian and New Zealand Journal of Medicine, 28(1), 1998, pp. 28-32
Authors:
NEWELL M
MILLIKEN S
CHIPMAN M
CEBON J
LEWIS C
GOLDSTEIN D
COOPER DA
Citation: M. Newell et al., DOX-SL (STEALTH LIPOSOMAL DOXORUBICIN HCL) MAINTENANCE THERAPY AFTER RESPONSE IN AIDS-RELATED KAPOSIS-SARCOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 15-15
Citation: Aj. Davis et al., LONG-TERM FOLLOW-UP OF CEOP IN THE TREATMENT OF HIV-RELATED NHL, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 95-95
Authors:
BROOKS P
SNOWDEN JA
FULLER A
MILLIKEN S
BIGGS JC
PASSUELLO F
Citation: P. Brooks et al., A RANDOMIZED, BLINDED, PLACEBO-CONTROLLED, PILOT PHASE-1 STUDY OF THETOLERABILITY OF FILGRASTIM IN PATIENTS WITH SEVERE ACTIVE RHEUMATOID-ARTHRITIS FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS, Arthritis and rheumatism, 40(9), 1997, pp. 131-131
Authors:
PERETTO C
LAROSA M
LIBONI A
MILLIKEN S
SOZZI M
ZARATTINI A
Citation: C. Peretto et al., THE SITE OF QUARTO DELLE CINFONARE IN THE CONTEXT OF THE LOWER PALEOLITHIC OF WEST-CENTRAL ITALY, L'Anthropologie, 101(4), 1997, pp. 597-615
Authors:
NEWELL M
GOLDSTEIN D
MILLIKEN S
LEWIS C
HOY J
THOMSON B
COOPER D
Citation: M. Newell et al., PHASE I II TRIAL OF FILGRASTIM (R-METHUG-CSF), CEOP CHEMOTHERAPY AND ANTIRETROVIRAL THERAPY IN HIV-RELATED NON-HODGKINS-LYMPHOMA/, Annals of oncology, 7(10), 1996, pp. 1029-1036
Authors:
NEWELL M
MILLIKEN S
CHIPMAN M
CEBON J
LEWIS C
GOLDSTEIN D
COOPER DA
Citation: M. Newell et al., DOX-SL (STEALTH LIPOSOMAL DOXORUBICIN HCL) MAINTENANCE THERAPY AFTER RESPONSE IN AIDS-RELATED KAPOSIS-SARCOMA, AIDS, 10, 1996, pp. 133-133
Authors:
ATKINSON K
DOWNS K
CONCANNON A
MILLIKEN S
Citation: K. Atkinson et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RELAPSED ACUTE MYELOID-LEUKEMIA (AML) - REPLY, Australian and New Zealand Journal of Medicine, 26(4), 1996, pp. 571-571
Authors:
ATKINSON K
DOWNS K
DODDS A
CONCANNON A
MILLIKEN S
Citation: K. Atkinson et al., 5-YEAR LEUKEMIA-FREE SURVIVAL OF 72-PERCENT AND 77-PERCENT FOR EARLY-STAGE ACUTE AND CHRONIC MYELOID-LEUKEMIA TREATED BY HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Australian and New Zealand Journal of Medicine, 26(1), 1996, pp. 54-58
Citation: P. Kearney et al., IMPROVED SPECIFICITY OF RIBOZYME-MEDIATED CLEAVAGE OF BCR-ABL MESSENGER-RNA, Experimental hematology, 23(9), 1995, pp. 986-989
Authors:
COE CL
CARROLL NC
ZENKER PN
THOMPSON SG
LOFGREN JP
ADAMS JS
KING J
HALL S
CARVER M
BEVILLE J
SWINGER GL
GATELEY KW
THORNER R
MILLIKEN S
NORBERG J
KELLEY M
ROBINSON L
CHAPMAN R
SIMPSON D
Citation: Cl. Coe et al., HUMAN RABIES - ALABAMA, TENNESSEE, AND TEXAS, 1994 (REPRINTED FROM MMWR, VOL 44, PG 269-272, 1995), JAMA, the journal of the American Medical Association, 273(17), 1995, pp. 1327-1328
Authors:
ATKINSON K
DODDS A
MILLIKEN S
CONCANNON A
FAY K
HARRIS M
FLECKNOEBROWN S
LIND D
MCKINLEY R
RUTOVITZ J
ROSENFELD D
HARVEY M
DOWNS K
FLATTERY D
SONG J
GREEN A
QUIGLEY V
HAWKINS T
Citation: K. Atkinson et al., AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY - TREATMENT-RELATED MORTALITY OF 2-PERCENT, Australian and New Zealand Journal of Medicine, 25(5), 1995, pp. 483-489
Authors:
KEARNEY PP
WRIGHT LA
MILLIKEN S
BIGGS JC
WILSON SB
Citation: Pp. Kearney et al., RIBOZYME AND ANTISENSE DNA REGULATION OF BCR ABL EXPRESSION IN CML PATIENTS/, Journal of cellular biochemistry, 1994, pp. 233-233
Authors:
KEARNEY P
WILSON S
WRIGHT L
MILLIKEN S
BIGGS J
Citation: P. Kearney et al., ANTISENSE OLIGOMERS TO REGULATE BCR-ABL GENE-EXPRESSION IN CHRONIC MYELOID-LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 748-748
Authors:
WRIGHT L
WILSON SB
MILLIKEN S
BIGGS J
KEARNEY P
Citation: L. Wright et al., RIBOZYME-MEDIATED CLEAVAGE OF THE BCR ABL TRANSCRIPT EXPRESSED IN CHRONIC MYELOID-LEUKEMIA/, Experimental hematology, 21(13), 1993, pp. 1714-1718
Authors:
ATKINSON K
DODDS AJ
CONCANNON AJ
MILLIKEN S
DOWNS K
MARSHALL G
WILSON F
STANIFORTH D
Citation: K. Atkinson et al., UNRELATED VOLUNTEER BONE-MARROW TRANSPLANTATION - INITIAL EXPERIENCE AT ST-VINCENTS-HOSPITAL, SYDNEY, Australian and New Zealand Journal of Medicine, 23(5), 1993, pp. 450-457
Authors:
ATKINSON K
BIGGS JC
CONCANNON AJ
DODDS AJ
MILLIKEN S
DOWNS K
MARSHALL G
WILSON F
YOUNG S
ASHBY M
MORGAN G
HARKNESS J
Citation: K. Atkinson et al., CHANGING RESULTS OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATIONIN PATIENTS WITH HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990, Australian and New Zealand Journal of Medicine, 23(2), 1993, pp. 181-186